Ads
related to: bristol-myers
Search results
Daily Spotlight: Profit Margins Widened in 1Q
Argus Research via Yahoo Finance· 5 hours agoFirst-quarter earnings season is winding down as the retailers wrap up their reports. The overall growth rate is set to land in the 7%-8% range. That's not bad -- and the rate would be higher ...
BMS Opdivo and Yervoy combo misses primary endpoint in Phase III NSCLC trial
Clinical Trials Arena via Yahoo Finance· 2 days agoBristol Myers Squibb’s (BMS) blockbuster cancer therapies Opdivo (nivolumab) and Yervoy (ipilimumab)...
Down but Not Out: 3 Stocks to Buy on a Post-Earnings Dip
Motley Fool via Yahoo Finance· 3 days agoThey found Starbucks (NASDAQ: SBUX), Datadog (NASDAQ: DDOG), andBristol Myers Squibb (NYSE: BMY)....
Drugmakers in Medicare Price Talks Spent Less on R&D Than on Shareholders, Marketing, Overhead:...
The Fiscal Times via Yahoo Finance· 6 days agoThe report says that the eight companies — Johnson & Johnson, Amgen, AstraZeneca, Bristol Myers...
Large Cap Trio for Value, Growth and Yield
MoneyShow via Yahoo Finance· 2 days agoWith a solid economy and a Fed still likely to cut interest rates this year, we believe the dividend yield of 2.6% and forward P/E ratio of 14 on our portfolio holdings are attractive, especially ...
India's Alembic Pharma posts higher Q4 profit on strong N.America sales
Reuters· 6 days agoIndian generic drugmaker Alembic Pharma reported a 17% rise in fourth-quarter profit on Thursday,...
Biogen Continues Its 20% Sprint On A Twist In Alzheimer's Treatment
Investor's Business Daily· 1 hour agoThe companies are submitting information on a rolling basis for approval of an under-the-skin...
Intel, Arm, Apple, GameStop rise premarket; Bristol Myers falls By Investing.com
Investing.com· 2 days agoIntel, Arm, Apple, GameStop rise premarket; Bristol Myers falls
Dividend Capture Captains: The 3 Best Blue-Chip Stocks for Tactical Traders
InvestorPlace· 1 day agoYou then sell it to book the dividend income, making little if any capital gains (that would be nice...
Prothena (PRTA) Q1 Earnings Miss Estimates on Higher R&D Expenses
Zacks via Yahoo Finance· 6 days agoTotal revenues in the first quarter were from license fees recognized under an agreement with Roche...